Nevirapine: Clinical Trials

166 trials of Nevirapine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

147 completed, 8 unknown, 7 terminated, 1 active not recruiting. 40 Phase 3, 38 Phase 4, 32 Phase 1, 32 Phase 2, 17 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 340Completed 35, Unknown 3, Active not recruiting 1, Terminated 1
Phase 438Completed 33, Unknown 3, Terminated 2
Phase 132Completed 28, Terminated 2, Recruiting 1, Unknown 1
Phase 232Completed 28, Terminated 2, Active not recruiting 1, Recruiting 1
Not applicable17Completed 15, Unknown 1, Withdrawn 1
Early Phase 11Completed 1

Follow Nevirapine: new trials by email Literature Review of Nevirapine trials Research Report on Nevirapine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Research on the Psychological Status of Patients With HIV-1 Infection
All kinds of INSTI medications, All kinds of conventional medications - HIV-1-infection, Anxiety Depression
Not yet recruitingShanxi Bethune Hospital5002025-08-012025-07-23
BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) Study
B/F/TAF, TDF/3TC/EFV or DTG or NVP, DMPA - Bone Loss
Phase 4UnknownMU-JHU CARE3302019-12-032023-04-07
Nevirapine / Lamivudine for HIV Maintenance Therapy
Neviparine (NVP)/ Lamivudine (3TC) - HIV Infection, Antiretroviral Treatment
Phase 4CompletedCantonal Hospital of St. Gallen2012019-04-122025-06-10
Neuropsychiatric Side Effects of Efavirenz in Children Living With HIV
Efavirenz, Nevirapine, Lopinavir-Ritonavir Drug Combination - Efavirenz, Child Behavior
CompletedRadboud University Medical Center1442017-06-192018-07-10
Population Pharmacokinetics of Antiretroviral in Children
Dolutegravir, Raltegravir, Rilpivirine - Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been Performed
CompletedAssistance Publique - Hôpitaux de Paris652017-06-162026-04-03
Nevirapine + 3TC Based Maintenance Therapy for HIV Infection
Nevirapine plus lamivudine - HIV Infections
Not applicableCompletedCantonal Hospital of St. Gallen202016-12-232018-07-18
Efficacy of Rilpivirine-based Regimens as Switch Therapy From Nevirapine-based Regimens in HIV-infected Patients
Nevirapine, Rilpivirine - Efficacy of Rilpivirine-based Regimens as Switch Therapy
Not applicableCompletedMahidol University1062016-12-012018-09-10
Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, Botswana
Zidovudine, Nevirapine - HIV, Insulin Sensitivity
Phase 4CompletedAnn & Robert H Lurie Children's Hospital of Chicago4952016-08-222022-07-20
Antiretroviral Regime for Viral Eradication in Newborns
Zidovudine, Nevirapine, Lamivudine - HIV/AIDS and Infections
Phase 4CompletedNational Center for Women and Children's Health, China CDC6002016-04-012022-09-28
Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial
Nevirapine, Zidovudine, Lamivudine - HIV
Phase 4CompletedColumbia University732015-08-012020-08-04
Early Infant HIV Treatment in Botswana
Nevirapine, Kaletra, Lamivudine - HIV, Pediatric AIDS
Phase 2 / Phase 3Active not recruitingHarvard School of Public Health (HSPH)672015-05-042026-02-23
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Nevirapine (NVP), Lopinavir/Ritonavir (LPV/r) - HIV Infection
Phase 1 / Phase 2RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)11202015-01-232026-09-09
Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy
triple therapy, dual therapy - HIV
Phase 3CompletedUniversity Hospital, Tours2242014-12-012025-12-26
Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)
Raltegravir (MK-0518), Nevirapine, Lamivudine - HIV Infections
Phase 2TerminatedMerck Sharp & Dohme LLC112014-09-032019-04-08
Multiple Dose BE Study With Nevirapine 400mg PR Tablets
Nevirapine, Viramune® - HIV-1
Phase 1CompletedRatiopharm GmbH462014-08-012015-08-25
A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy
Levonorgestrel, Nevirapine, Efavirenz - HIV, Contraception
Phase 2CompletedUniversity of Nebraska602014-03-042023-09-01
Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected
Lopinavir/ritonavir, Emtricitabine/tenofovir disoproxil fumarate, Efavirenz - HIV-1 Infection, Pf Subclinical Parasitemia
Phase 1 / Phase 2CompletedAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections522014-01-102019-08-06
Moringa Oleifera- Antiretroviral Pharmacokinetic Drug Interaction
Moringa oleifera, Efavirenz 600mg, Nevirapine 200Mg Oral Tablet - HIV
CompletedUniversity of Zimbabwe192013-01-012019-04-02
A Study to Evaluate the Effects of Genetic Factors on the Pharmacokinetics of Antiretroviral Drugs During Pregnancy and Lactation
Efavirenz, Nevirapine - HIV, Pregnancy
CompletedAdeniyi Olagunju4602012-12-012017-09-06
Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
8 hourly LPV/r during TB treatment, Nevirapine, Lopinavir/Ritonavir - Tuberculosis, HIV
Phase 4CompletedUniversity of Cape Town2002012-11-012017-10-27

Showing 20 of 166. Sign in to see all of them.

Conditions studied

HIV Infections (129)  ·  Acquired Immunodeficiency Syndrome (28)  ·  AIDS-Related Complex (9)  ·  Tuberculosis (8)  ·  Pregnancy Complications, Infectious (7)  ·  Breast Feeding (5)  ·  Lipodystrophy (3)  ·  Coinfection (2)  ·  HIV-Associated Lipodystrophy Syndrome (2)  ·  Hepatic Insufficiency (2)  ·  Malaria (2)  ·  AIDS Dementia Complex (1)  ·  AIDS-Related Opportunistic Infections (1)  ·  Bacteremia (1)  ·  Bone Diseases, Metabolic (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (50)  ·  Boehringer Ingelheim (35)  ·  Germans Trias i Pujol Hospital (4)  ·  Harvard School of Public Health (HSPH) (3)  ·  Makerere University (3)  ·  Abbott (2)  ·  Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (2)  ·  Bamrasnaradura Infectious Diseases Institute (2)  ·  Bristol-Myers Squibb (2)  ·  Cantonal Hospital of St. Gallen (2)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)  ·  French National Agency for Research on AIDS and Viral Hepatitis (2)  ·  International Maternal Pediatric Adolescent AIDS Clinical Trials Group (2)  ·  Radboud University Medical Center (2)  ·  University of California, San Diego (2)

Countries

United States (60)  ·  South Africa (21)  ·  Puerto Rico (20)  ·  Uganda (15)  ·  Spain (13)  ·  Thailand (13)  ·  Malawi (12)  ·  France (10)  ·  Botswana (9)  ·  United Kingdom (9)  ·  Zimbabwe (9)  ·  Tanzania (8)  ·  Brazil (7)  ·  India (7)  ·  Kenya (6)

Top investigators

Andrew Wiznia (2)  ·  Bonaventura Clotet, MD,PhD (2)  ·  James McIntyre, MBChB, MRCOG (2)  ·  Jane Hitti, MD, MPH (2)  ·  Ram Yogev, MD (2)  ·  Sullivan JL (2)  ·  Abdel K Traore, MD (1)  ·  Adeniyi Olagunju (1)  ·  Adeodata Kekitiinwa, MD (1)  ·  Alan Landay (1)  ·  Alan Winston (1)  ·  Alejandro Dorenbaum (1)  ·  Alejandro Dorenbaum, MD (1)

Results publications

PMID 18657709, PMID 15687448, PMID 18090046, PMID 18366444, PMID 21124227, PMID 21266910, PMID 24086319, PMID 24326304, PMID 26684818, PMID 10485720, PMID 10659875, PMID 10954886, PMID 11306155, PMID 11372025, PMID 11509999, PMID 11600822, PMID 11840078, PMID 11880966, PMID 11927734, PMID 11980557, PMID 12439209, PMID 12590791, PMID 12730418, PMID 13678973, PMID 14519801, PMID 14617507, PMID 14657758, PMID 14669723, PMID 14678593, PMID 14722443, PMID 15115831, PMID 15213559, PMID 15242535, PMID 15287983, PMID 15633090, PMID 15652610, PMID 15750399, PMID 16105190, PMID 16123677, PMID 16131307, PMID 16136470, PMID 16159645, PMID 16220085, PMID 16227794, PMID 16284468, PMID 16287792, PMID 16470119, PMID 16511414, PMID 16522393, PMID 16816557

NIH funding

2008 (2), U01AI068632 (2), U01AI068636 (2), 2004 (1), 2005 (1), 2014 (1), K24AI051966 (1), R01AI062512 (1), R01DK109881 (1), R01HD023412 (1), R01HD052461 (1), R01HD056953 (1), R01HL065953 (1), R01MH058076 (1), R01MH092225 (1)